Cardiac Dysfunction in Patients with Fatty Liver Disease
Cirrhotic Cardiomyopathy and Cardiac Dysfunction in Patients with Metabolic Dysfunction Associated Steatotic Liver Disease
Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh
This observational or N/A phase trial investigates Cardiac Disease and Fatty Liver and is currently actively recruiting participants. Post Graduate Institute of Medical Education and Research, Chandigarh leads this study, which shows 4 recorded versions since 2023 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.
Status Flow
Change History
4 versions recorded-
Feb 2025 — Present [monthly]
Recruiting
-
Sep 2024 — Feb 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
May 2024 — Jul 2024 [monthly]
Recruiting
First recorded
Jul 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Post Graduate Institute of Medical Education and Research, Chandigarh
For direct contact, visit the study record on ClinicalTrials.gov .